Sustained Improvement in Time in Range After Automated Insulin Delivery Initiation in Adolescents and Adults With Type 1 Diabetes Mellitus: A 12-Month Prospective Observational Study From Saudi Arabia

Background: Automated insulin delivery (AID) improves glycemic outcomes in trials, but long-term real-world data on comprehensive continuous glucose monitoring (CGM) metrics remain limited in the Middle East. Methods: We conducted a prospective observational cohort study of adults with type 1 diabetes mellitus (T1DM) initiating Control-IQ (CIQ) or MiniMed 780G (MMG) at King Fahad Medical City, Riyadh, Saudi Arabia, between December 2023 and November 2025. Participants were followed for 12 months. Continuous glucose monitoring outcomes included time in range (TIR: 70-180 mg/dL), time above range (TAR), time below range (TBR), glycemic management indicator (GMI), mean sensor glucose, and coefficient of variation (CV) and assessed at baseline and 6 post-initiation time points. Glycated hemoglobin A1c (HbA1c) was assessed using paired pre- and post-AID values. Results: A total of 132 adults were included: 76 using CIQ and 56 using MMG. Mean age was 27.2 ± 7.7 years, 68.9% were female, and mean diabetes duration was 14.5 ± 7.9 years. Time in range increased from 59.0 ± 15.4% at baseline to 72.3 ± 10.2% at 2 weeks and remained sustained at 12 months (73.5 ± 11.5%; +15.1 percentage points; P < .001). Time below range <70 mg/dL decreased from 5.3 ± 5.3 to 1.4 ± 1.2%. Glycated hemoglobin A1c decreased from 7.42 ± 1.13 to 6.52 ± 0.73% ( P < .001; n = 106). Time in range ≥70% increased from 29.0% to 71.0%, and HbA1c <7% increased from 30.3% to 74.5%. Severe hypoglycemia and diabetic ketoacidosis rates were significantly reduced. Conclusion: In a Saudi tertiary diabetes center, AID initiation was associated with rapid and sustained 12-month improvements in TIR, HbA1c, hypoglycemia exposure, and acute diabetes-related events.

Authors

Institutions

Publication Details

Journal
Journal of Diabetes Science and Technology
Published
2026-11-19
DOI
https://doi.org/10.1177/19322968261502745
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sustained Improvement in Time in Range After Automated Insulin Delivery Initiation in Adolescents and Adults With Type 1 Diabetes Mellitus: A 12-Month Prospective Observational Study From Saudi Arabia

SAAD H. ALZAHRANI, Imad Addin Brema, Mohammed S. Almehthel, Ali Mohammed Alqahtani et al.
Journal of Diabetes Science and Technology
Diabetes Management and Research
article

Sustained Improvement in Time in Range After Automated Insulin Delivery Initiation in Adolescents and Adults With Type 1 Diabetes Mellitus: A 12-Month Prospective Observational Study From Saudi Arabia

SAAD H. ALZAHRANI, Imad Addin Brema, Mohammed S. Almehthel, Ali Mohammed Alqahtani, Ahmad Alobedollah, Nouf Aboalsamh, Maswood M. Ahmad, Sara Binbaz, Mai Albogami
article en

Abstract

Background: Automated insulin delivery (AID) improves glycemic outcomes in trials, but long-term real-world data on comprehensive continuous glucose monitoring (CGM) metrics remain limited in the Middle East. Methods: We conducted a prospective observational cohort study of adults with type 1 diabetes mellitus (T1DM) initiating Control-IQ (CIQ) or MiniMed 780G (MMG) at King Fahad Medical City, Riyadh, Saudi Arabia, between December 2023 and November 2025. Participants were followed for 12 months. Continuous glucose monitoring outcomes included time in range (TIR: 70-180 mg/dL), time above range (TAR), time below range (TBR), glycemic management indicator (GMI), mean sensor glucose, and coefficient of variation (CV) and assessed at baseline and 6 post-initiation time points. Glycated hemoglobin A1c (HbA1c) was assessed using paired pre- and post-AID values. Results: A total of 132 adults were included: 76 using CIQ and 56 using MMG. Mean age was 27.2 ± 7.7 years, 68.9% were female, and mean diabetes duration was 14.5 ± 7.9 years. Time in range increased from 59.0 ± 15.4% at baseline to 72.3 ± 10.2% at 2 weeks and remained sustained at 12 months (73.5 ± 11.5%; +15.1 percentage points; P < .001). Time below range <70 mg/dL decreased from 5.3 ± 5.3 to 1.4 ± 1.2%. Glycated hemoglobin A1c decreased from 7.42 ± 1.13 to 6.52 ± 0.73% ( P < .001; n = 106). Time in range ≥70% increased from 29.0% to 71.0%, and HbA1c <7% increased from 30.3% to 74.5%. Severe hypoglycemia and diabetic ketoacidosis rates were significantly reduced. Conclusion: In a Saudi tertiary diabetes center, AID initiation was associated with rapid and sustained 12-month improvements in TIR, HbA1c, hypoglycemia exposure, and acute diabetes-related events.

Journal of Diabetes Science and Technology
University of British Columbia (CA), King Fahd Medical City (SA)
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon